Sunday, September 28, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Oracle Faces Analyst Scrutiny Over Cloud Business Model

Dieter Jaworski by Dieter Jaworski
September 28, 2025
in Stocks
0
Oracle Stock
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

A surprising critique from Wall Street is challenging the narrative around Oracle’s cloud computing ambitions. Despite announcing several high-profile artificial intelligence partnerships, the technology veteran now faces tough questions about its fundamental business model and profit potential.

Questioning the Cloud Strategy

Research firm Redburn Atlantic has issued a stark warning to investors, assigning a “Sell” rating to Oracle shares. Their analysis presents a concerning picture: Oracle may be acting more as a financier for major cloud projects rather than operating as a traditional cloud provider. This approach could result in significantly thinner profit margins than the market currently anticipates.

The firm’s researchers express particular skepticism about Oracle’s ability to capitalize on billion-dollar AI initiatives. While partners like OpenAI stand to generate substantial returns, Oracle might be locked into fixed-price contracts that limit its upside potential. According to Redburn, Oracle Cloud Infrastructure (OCI) already carries inflated valuations that incorporate what they describe as a “high-risk future scenario.”

Should investors sell immediately? Or is it worth buying Oracle?

Major AI Deals Paint Contrasting Picture

Oracle’s recent business developments tell a different story. The company has secured an impressive portfolio of AI-related agreements that suggest strong growth prospects:

  • A strategic partnership with OpenAI forms the cornerstone of Oracle’s five-year expansion strategy
  • Collaboration with SoftBank will establish five new AI data centers supporting OpenAI’s Stargate platform
  • The Stargate initiative carries an estimated total value exceeding $300 billion
  • Ongoing discussions with Meta could yield a $20 billion agreement for AI training services

Institutional Investors Show Diverging Views

This conflicting evidence is reflected in investment patterns across financial institutions. Michels Family Financial substantially reduced its Oracle holdings by nearly 40 percent, while other funds modestly increased their positions. The mixed response from professional money managers highlights the uncertainty surrounding Oracle’s true positioning within the AI sector.

The central debate remains unresolved: Will Oracle emerge as a dominant force in the AI revolution, or will the company primarily enable others’ success while capturing limited value for itself?

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from September 28 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 28.

Oracle: Buy or sell? Read more here...

Tags: Oracle
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

NRX Pharmaceuticals Stock
Stocks

NRX Pharmaceuticals Receives Critical FDA Clearance for Ketamine Product

September 28, 2025
Berry Petroleum Stock
Stocks

California Energy Sector Reshaped as Berry Petroleum Acquisition Finalizes

September 28, 2025
BuzzFeed Stock
Stocks

Can BuzzFeed’s New Strategy Reverse Its Stock Decline?

September 28, 2025
Next Post
Microsoft Stock

Microsoft Shares Face Political Crosswinds Amid Strong Fundamentals

MP Materials Stock

Rare Earth Miner Faces Competitive Challenge as Startup Secures Major Backing

Amazon Stock

Amazon Stock: Technical Indicators Clash With Strong Fundamentals

Recommended

DexCom Stock

DexCom Shares Face Mounting Challenges Amid Regulatory Setbacks and Leadership Uncertainty

1 day ago
Kraft Heinz Stock

Kraft Heinz Split: Strategic Masterstroke or Act of Desperation?

4 days ago
Microsoft Stock

Microsoft Shares: Analysts Shift Focus to Cloud and AI Potential

1 day ago
Meta Stock

Tech Titans Clash: Assessing the Meta vs. Snap Investment Proposition

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Face Mounting Pressure Despite Solid Fundamentals

Nvidia’s Landmark AI Infrastructure Partnership with OpenAI Sparks Market Debate

Alphabet Shares Surge as Court Delivers Favorable Antitrust Ruling

Amazon Stock: Technical Indicators Clash With Strong Fundamentals

Rare Earth Miner Faces Competitive Challenge as Startup Secures Major Backing

Microsoft Shares Face Political Crosswinds Amid Strong Fundamentals

Trending

NRX Pharmaceuticals Stock
Stocks

NRX Pharmaceuticals Receives Critical FDA Clearance for Ketamine Product

by Robert Sasse
September 28, 2025
0

NRX Pharmaceuticals shares are positioned for a potentially transformative period following a pivotal regulatory development. The U.S....

Berry Petroleum Stock

California Energy Sector Reshaped as Berry Petroleum Acquisition Finalizes

September 28, 2025
BuzzFeed Stock

Can BuzzFeed’s New Strategy Reverse Its Stock Decline?

September 28, 2025
Procter & Gamble Stock

Procter & Gamble Shares Face Mounting Pressure Despite Solid Fundamentals

September 28, 2025
Nvidia Stock

Nvidia’s Landmark AI Infrastructure Partnership with OpenAI Sparks Market Debate

September 28, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • NRX Pharmaceuticals Receives Critical FDA Clearance for Ketamine Product
  • California Energy Sector Reshaped as Berry Petroleum Acquisition Finalizes
  • Can BuzzFeed’s New Strategy Reverse Its Stock Decline?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com